Drug Pipeline

MHB018A injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Phase 3
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-02 NCT07620405 Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease Phase 3 Not Yet Recruiting
2026-06-02 NCT07622121 Treatment of Chronic Thyroid Eye Disease With MHB018A Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07257185 MHB018A Treatment in Patients With Chronic Thyroid Eye Disease Thyroid Eye Disease (TED) Recruiting
NCT07262476 Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease Thyroid Eye Disease (TED) Recruiting
NCT07620405 Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease Thyroid Eye Disease (TED) Not Yet Recruiting
NCT07622121 Treatment of Chronic Thyroid Eye Disease With MHB018A Thyroid Eye Disease, TED Not Yet Recruiting
Sponsors Running MHB018A injection Trials
Minghui Pharmaceutical (Hangzhou) Ltd (4)
Get alerts when MHB018A injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free